“With Evo, most patients experience a dramatic improvement in vision right after the procedure,” Dr. Ling said in a news release.
The practice said April 27 that it is among the first in the U.S. to offer the procedure. The Evo lens is smaller than a typical contact lens and is implanted between the iris and the natural lens and does not involve the removal of corneal tissue.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.